C.Q. Pharmaceutical Holding Co., Ltd. (SHE:000950)
4.940
+0.010 (0.20%)
May 23, 2025, 2:45 PM CST
SHE:000950 Revenue
In the year 2024, C.Q. Pharmaceutical Holding had annual revenue of 80.56B CNY with 0.55% growth. C.Q. Pharmaceutical Holding had revenue of 20.61B in the quarter ending March 31, 2025, with 5.03% growth.
Revenue
80.56B
Revenue Growth
+2.76%
P/S Ratio
0.11
Revenue / Employee
5.56M
Employees
14,485
Market Cap
8.50B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 80.56B | 442.42M | 0.55% |
Dec 31, 2023 | 80.12B | 12.29B | 18.12% |
Jan 1, 2023 | 67.83B | 5.31B | 8.49% |
Dec 31, 2021 | 62.52B | 17.30B | 38.26% |
Dec 31, 2020 | 45.22B | 11.38B | 33.61% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 29.19B |
Shenzhen Mindray Bio-Medical Electronics | 35.59B |
WuXi AppTec | 39.59B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
Aier Eye Hospital Group | 21.81B |
Shanghai United Imaging Healthcare | 10.43B |
Sichuan Biokin Pharmaceutical | 5.82B |
Yunnan Baiyao Group Co.,Ltd | 40.10B |